REFERENCES
- Chapman LR, Stockley RA, Dawkins C, Wilkes MM, Navickis RJ. Augmentation therapy for alpha1 antitrypsin deficiency: a meta-analysis. COPD 2009 Jun; 6:177–184.
- Dirksen A, Dijkman JH, Madsen F, A randomized clinical trial of alpha(1)-antitrypsin augmentation therapy. Am J Respir Crit Care Med 1999; 160:1468–1472.
- Wencker M, Fuhrmann B, Banik N, Konietzko N. Longitudinal follow-up of patients with alpha(1)-protease inhibitor deficiency before and during therapy with IV alpha(1)-protease inhibitor. Chest 2001 Mar; 119:737–744.
- Tashkin DP, Celli B, Senn S, A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 2008: 359:1543–1554
- Silverman EK, Sandhaus RA. Alpha1-antitrypsin deficiency. N Engl J Med 2009; 360:2749–2757.
- Mullins CD, Huang X, Merchant S, Stoller JK. The Direct Medical Costs of α1-Antitrypsin Deficiency Chest 2001; 119:745–752.